Recent investigations into retatrutide, a dual agonist for GLP-1 and GIP receptors, are revealing significant outcomes in managing weight gain and related second-type diabetes. Preclinical evidence suggest a distinct https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/